A number of research firms have changed their ratings and price targets for GNC Holdings (NYSE: GNC):

  • 8/2/2017 – GNC Holdings was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.
  • 7/31/2017 – GNC Holdings was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “GNC Holdings exited the second quarter of 2017 on a disappointing note with revenues missing the Zacks Consensus Estimate. Although earnings exceeded the consensus estimate, the year-over-year decline on both the fronts was a huge disappointment. The decline can be attributed to lower sales in the company’s U.S. & Canada and manufacturing/wholesale segments. Also, the decline in gross and adjusted operating margin is a matter of concern. In this regard we note that, over the past one year, GNC Holdings has been trading below the broader industry. On a positive note, during the second quarter, management witnessed positive response for its New GNC Plan. New consumer enrollment under the myGNC Rewards Program and launch of GNC storefront on Amazon buoy optimism. Also, the company’s consistent growth in international business and strong cash position are encouraging.”
  • 7/28/2017 – GNC Holdings had its price target raised by analysts at Barclays PLC from $7.00 to $9.00. They now have an “underweight” rating on the stock.
  • 7/25/2017 – GNC Holdings was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating.
  • 7/19/2017 – GNC Holdings was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Over the past one year, GNC Holdings has been trading below the broader Retail-Drug Store industry. The company has declined 67.3%, as compared to 15.8% decline in the broader industry over this period. Weak margin scenario and significant decline in revenue on year-over-year basis raises concern. Tough competition, changing consumer preferences along with FTC regulations continue to pose challenges. In this regard, we note that during the last reported quarter result, market was disappointed with the company’s year-over-year operating result with declining revenues and earnings performance on lower sales in the U.S. & Canada and manufacturing/ wholesale segments. On a positive note, management expects to deliver positive performance banking on its One New GNC plan for operational improvement. Also, the company’s consistent growth in international business and strong cash position are encouraging.”
  • 7/19/2017 – GNC Holdings was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 7/8/2017 – GNC Holdings was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 7/4/2017 – GNC Holdings was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “For the majority of the last three months, GNC Holdings has been trading above the broader Retail-Drug Store industry. Post a promising first quarter performance, the market is upbeat on the stock’s strong future potential. Management expects to deliver positive performance banking on its One New GNC plan for operational improvement. Also, the company’s consistent growth in international business and strong cash position are encouraging. On the flip side, weak margin scenario, tough competition and changing consumer preferences along with FTC regulations continue to pose challenges. In this regard, we note that during the last reported quarter result, market was disappointed with the company’s year-over-year operating result with declining revenues and earnings performance on lower sales in the U.S. & Canada and manufacturing/ wholesale segments.”
  • 6/20/2017 – GNC Holdings was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $8.50 price target on the stock. According to Zacks, “GNC Holdings ended the first quarter 2017 with both earnings and sales outpacing the Zacks Consensus Estimate. On the contrary, market is disappointed with the company’s year-over-year operating result with declining revenues and earnings performance on lower sales in the U.S. & Canada and manufacturing/wholesale segments. Additionally, weak margin scenario, tough competition and changing consumer preferences along with FTC regulations continue to pose challenges. Notably, over the last three months, GNC Holdings was trading below the broader Retail-Drug Store industry. However the share price has hot up of late post its first quarter earnings. On a positive note, management reported bullish trends with regard to its One New GNC plan for operational improvement. Also, the company’s growth in international business and strong cash position in the reported quarter are encouraging.”

Shares of GNC Holdings, Inc. (NYSE GNC) opened at 9.60 on Thursday. The stock’s market cap is $657.29 million. GNC Holdings, Inc. has a one year low of $6.51 and a one year high of $22.32. The firm has a 50-day moving average price of $8.61 and a 200-day moving average price of $8.02.

GNC Holdings (NYSE:GNC) last announced its quarterly earnings results on Thursday, July 27th. The specialty retailer reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. GNC Holdings had a negative net margin of 14.56% and a positive return on equity of 285.93%. The company had revenue of $640.99 million for the quarter, compared to analyst estimates of $646.48 million. During the same quarter last year, the business earned $0.79 earnings per share. GNC Holdings’s revenue was down 4.8% compared to the same quarter last year. Analysts anticipate that GNC Holdings, Inc. will post $1.36 earnings per share for the current fiscal year.

In other news, Director Alan D. Feldman purchased 36,400 shares of the company’s stock in a transaction on Tuesday, May 16th. The shares were bought at an average price of $6.87 per share, for a total transaction of $250,068.00. Following the completion of the purchase, the director now owns 47,337 shares of the company’s stock, valued at $325,205.19. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Robert F. Moran purchased 300,000 shares of the company’s stock in a transaction on Friday, May 12th. The stock was purchased at an average price of $6.69 per share, for a total transaction of $2,007,000.00. Following the purchase, the chief executive officer now directly owns 953,271 shares of the company’s stock, valued at approximately $6,377,382.99. The disclosure for this purchase can be found here. Insiders acquired 354,400 shares of company stock worth $2,388,048 in the last 90 days. 1.85% of the stock is owned by company insiders.

GNC Holdings, Inc is a specialty retailer of health, wellness and performance products, which include protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. The Company’s operations consist of purchasing raw materials, formulating and manufacturing products and selling the finished products.

Receive News & Stock Ratings for GNC Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC Holdings Inc and related stocks with our FREE daily email newsletter.